ArticleInterdisciplinary sciences, computational life sciences2025
HAFMMDA: HIN2vec-Based Attentional Factorization Machines for Predicting Microbe-Drug Associations.
Article in Interdisciplinary sciences, computational life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Emerging research continues to reveal the fundamental contributions of microbial communities to maintaining human physiological balance and advancing drug discovery. However, established wet-lab investigation techniques require significant time and resources. Contemporary research efforts have predominantly concentrated on establishing robust computational architectures to predict microbe-drug associations. Our research establishes a neural network architecture that synthesizes heterogeneous biological relationships with attentional factorization machines (HAFMMDA) to predict undiscovered microbe-drug linkages. The initial step involves assembling a heterogeneous network architecture integrating three key components: microbe similarity networks, drug similarity networks, and established microbe-drug interaction networks. HAFMMDA utilizes HIN2vec to extract feature representations of microbe-drug pairs. Finally, it combines second-order feature interactions and attention mechanism to perform comprehensive prediction. Five-fold cross-validation results confirmed excellent predictive performance with an AUC score of 0.9805, demonstrating statistically significant improvements over five contemporary baseline approaches. These findings corroborate HAFMMDA's effectiveness in uncovering verified drug-microorganism associations while simultaneously predicting innovative therapeutic-microbe relationships.
Indexed as
Identifiers
40739061What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.